2019 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF):
- Silent period 10 January 2019
- Annual report 2018 7 February 2019
- Annual General Meeting to be held 13 March 2019
at ALK 4.00 p.m.
Bøge Allé 1
2970 Hørsholm, Denmark
Written requests to have specific business
transacted at the AGM will be included in the
agenda if received by the company on
29 January 2019 at the latest
(may be e-mailed to investor@alk.net)
- Silent period 11 April 2019
- Three-month interim report (Q1) 2019 9 May 2019
- Silent period 16 July 2019
- Six-month interim report (Q2) 2019 13 August 2019
- Silent period 10 October 2019
- Nine-month interim report (Q3) 2019 7 November 2019
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 2014
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,300 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.
Attachment
